蘭大18秋《醫(yī)學(xué)免疫學(xué)A(滿分)(共8頁)_第1頁
蘭大18秋《醫(yī)學(xué)免疫學(xué)A(滿分)(共8頁)_第2頁
蘭大18秋《醫(yī)學(xué)免疫學(xué)A(滿分)(共8頁)_第3頁
蘭大18秋《醫(yī)學(xué)免疫學(xué)A(滿分)(共8頁)_第4頁
蘭大18秋《醫(yī)學(xué)免疫學(xué)A(滿分)(共8頁)_第5頁
已閱讀5頁,還剩3頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

1、精選優(yōu)質(zhì)文檔-傾情為你奉上單選題NK細(xì)胞的表面標(biāo)志是A: <span>CD3</span><sup>-</sup><span>、CD19</span><sup>-</sup><span>、CD56</span><sup>+</sup><span>、CD16</span><sup>+</sup>B: <span>CD3</span><sup>+</sup>&l

2、t;span>、CD19</span><sup>-</sup><span>、CD56</span><sup>-</sup><span>、CD16</span><sup>+</sup>C: <span>CD3</span><sup>+</sup><span>、CD19</span><sup>-</sup><span>、CD56</span>&

3、lt;sup>-</sup><span>、CD16</span><sup>-</sup>D: <span>CD3</span><sup>+</sup><span>、CD19</span><sup>-</sup><span>、CD56</span><sup>+</sup><span>、CD16</span><sup>+</sup>E: <

4、;span>CD3</span><sup>+</sup><span>、CD19</span><sup>+</sup><span>、CD56</span><sup>+</sup><span>、CD16</span><sup>+</sup>單選題人類的中樞免疫器官包括A: <span>扁桃體和闌尾</span>B: <span>骨髓和腔上囊</span>C: <

5、span>骨髓和胸腺</span>D: <span>脾和淋巴結(jié)</span>E: <span>腸相關(guān)淋巴組織</span>單選題與強(qiáng)直性脊柱炎發(fā)生密切相關(guān)的HLA分子是A: <span>HLA-DR5分子</span>B: <span>HLA-DR8分子</span>C: <span>HLA-B27分子</span>D: <span>HLA-B7分子</span>E: <span>HLA-DR3分子</span>

6、;單選題IgG的重鏈稱為A: <span>鏈</span>B: <span>鏈</span>C: <span>鏈</span>D: <span>鏈</span>E: <span>鏈</span>單選題脾小結(jié)生發(fā)中心內(nèi)聚集的免疫細(xì)胞主要是A: <span>增殖分化的B細(xì)胞</span>B: <span>并指樹突狀細(xì)胞</span>C: <span>增殖分化的Th1細(xì)胞</span>D: <span&g

7、t;巨噬細(xì)胞</span>E: <span>增殖分化的CTL細(xì)胞</span>單選題型超敏反應(yīng)造成組織損傷的重要因素是A: <span>免疫復(fù)合物的形成 </span>B: <span>免疫復(fù)合物激活補(bǔ)體 </span>C: <span>免疫復(fù)合物的沉積 </span>D: <span>炎癥細(xì)胞聚集 </span>E: <span>中性粒細(xì)胞溶酶體酶的釋放</span>單選題T細(xì)胞表面參與抗原識別及其信號轉(zhuǎn)導(dǎo)的受體是A: <span&

8、gt;TCR-CD3復(fù)合體</span>B: <span>BCR-Ig/Ig復(fù)合體</span>C: <span>TCR輔助受體</span>D: <span>BCR輔助受體</span>E: <span>Toll樣受體(TLR)</span>單選題TD-Ag引發(fā)免疫應(yīng)答的特點(diǎn)是A: <span>誘導(dǎo)抗體產(chǎn)生無需T細(xì)胞輔助</span>B: <span>主要誘導(dǎo)產(chǎn)生IgM類抗體</span>C: <span>不能刺激機(jī)體產(chǎn)生免疫

9、記憶</span>D: <span>只能誘導(dǎo)產(chǎn)生體液免疫應(yīng)答</span>E: <span>可誘導(dǎo)產(chǎn)生體液和細(xì)胞免疫應(yīng)答</span>單選題細(xì)胞因子不包括A: <span>淋巴毒素</span>B: <span>過敏毒素</span>C: <span>白細(xì)胞介素</span>D: <span>干擾素</span>E: <span>集落刺激因子</span>單選題具有補(bǔ)體Clq結(jié)合點(diǎn)的抗體是A: <span>

10、;IgG和IgE類抗體</span>B: <span>IgG和IgM類抗體</span>C: <span>IgA和IgG類抗體</span>D: <span>IgD和IgM類抗體</span>E: <span>IgA和IgE類抗體</span>單選題CTL殺傷靶細(xì)胞的特點(diǎn)A: <span>無需細(xì)胞直接接觸 </span>B: <span>作用無特異性 </span>C: <span>不需細(xì)胞因子參與 </span>D

11、: <span>不需要抗原刺激 </span>E: <span>釋放穿孔素、顆粒酶和表達(dá)FasL</span>單選題具有抗原加工提呈作用的專職APC是A: <span>內(nèi)皮細(xì)胞</span>B: <span>成纖維細(xì)胞</span>C: <span>病毒感染細(xì)胞</span>D: <span>樹突狀細(xì)胞</span>E: <span>腫瘤細(xì)胞</span>單選題機(jī)體再次體液免疫應(yīng)答發(fā)生的主要部位是A: <span>脾

12、</span>B: <span>骨髓</span>C: <span>胸腺</span>D: <span>淋巴結(jié)</span>E: <span>黏膜相關(guān)淋巴組織</span>單選題在抗寄生蟲免疫應(yīng)答中發(fā)揮重要作用的免疫細(xì)胞是A: <span>中性粒細(xì)胞</span>B: <span>嗜酸性粒細(xì)胞</span>C: <span>嗜堿性粒細(xì)胞</span>D: <span>單核細(xì)胞</span>E:

13、 <span>肥大細(xì)胞</span>單選題B細(xì)胞抗原識別受體是A: <span>TCR </span>B: <span>CD3 </span>C: <span>FcR </span>D: <span>CR2 </span>E: <span>smIg </span>單選題巨噬細(xì)胞所不具備的的受體是A: <span>C3b受體</span>B: <span>特異性抗原識別受體</span>C: <spa

14、n>Toll樣受體</span>D: <span>IgG Fc受體</span>E: <span>甘露糖受體</span>單選題肥大細(xì)胞表面能與IgE抗體Fc段結(jié)合的受體是A: <span>FcR</span>B: <span>FcR</span>C: <span>FcR</span>D: <span>FcR</span>E: <span>TLR</span>單選題ABO血型的天然抗體是A: <span&

15、gt;IgA類抗體 </span>B: <span>IgM類抗體</span><sub> </sub>C: <span>IgG類抗體</span><sub> </sub>D: <span>IgD類抗體 </span>E: <span>IgE類抗體 </span>單選題B1細(xì)胞接受多糖抗原刺激后可產(chǎn)生A: <span>以IgMt為主的高親和性抗體</span>B: <span>以IgG為主的高親和性抗體&l

16、t;/span>C: <span>以IgM為主的低親和性抗體</span>D: <span>以IgG為主的低親和性抗體</span>E: <span>IgM和IgG兩種不同類型的抗體</span>單選題動物來源的破傷風(fēng)抗毒素對人而言是A: <span>半抗原 </span>B: <span>抗體 </span>C: <span>抗原 </span>D: <span>既是抗體又是抗原 </span>E: <span&g

17、t;超抗原 </span>單選題屬于中樞免疫器官的是A: <span>扁桃體</span>B: <span>淋巴結(jié)</span>C: <span>胸腺 </span>D: <span>脾臟</span>E: <span>腸淋巴組織</span>單選題毛細(xì)血管內(nèi)T、B細(xì)胞進(jìn)入淋巴結(jié)的部位是A: <span>高內(nèi)皮微靜脈</span>B: <span>輸入淋巴管</span>C: <span>中央動脈<

18、/span>D: <span>被膜下竇</span>E: <span>邊緣區(qū)</span>單選題能與類風(fēng)濕因子特異性結(jié)合的物質(zhì)是A: <span>自身IgM分子t</span>B: <span>自身IgG分子t</span>C: <span>自身變性IgM分子</span>D: <span>自身變性IgG分子t</span>E: <span>自身變性IgE分子</span>單選題B細(xì)胞活化的第二信號是A: <span

19、> TCR與抗原肽-MHC復(fù)合物結(jié)合</span>B: <span> CD40與CD40L結(jié)合</span>C: <span> BCR與抗原結(jié)合</span>D: <span> CD28與B7結(jié)合</span>E: <span> CD19與抗原結(jié)合</span>單選題表達(dá)于APC表面可誘導(dǎo)Th細(xì)胞產(chǎn)生活化第一信號的物質(zhì)是A: <span> B7-1/2分子</span>B: <span> 抗原肽-MHC-類分子復(fù)合物</span>C:

20、 <span> ICAM-1分子</span>D: <span> 抗原肽-MHC-類分子復(fù)合物</span>E: <span> 脂類抗原-CD1分子復(fù)合物</span>單選題抗體分為五類的依據(jù)是A: <span>CH抗原性不同</span>B: <span>VH抗原性不同</span>C: <span>CL抗原性不同</span>D: <span>CH和CL抗原性不同</span>E: <span>VH和VL抗原性不

21、同</span>單選題預(yù)防I型超敏反應(yīng)發(fā)生最有效的方法是A: <span>查明變應(yīng)原,避免與之接觸或使用t</span>B: <span>應(yīng)用生物活性介質(zhì)拮抗劑t</span>C: <span>應(yīng)用抑制生物活性介質(zhì)合成的藥物t</span>D: <span>應(yīng)用抑制生物活性介質(zhì)釋放的藥物t</span>E: <span>特異性變應(yīng)原脫敏治療</span>單選題可將IgG裂解為2個Fab片段的酶類物質(zhì)是A: <span>胃蛋白酶</span>

22、B: <span>胰蛋白酶</span>C: <span>溶菌酶</span>D: <span>木瓜蛋白酶</span>E: <span>絲氨酸蛋白酶</span>單選題T細(xì)胞抗原識別受體是A: <span>BCR </span>B: <span>PRR </span>C: <span>TCR </span>D: <span>CDR </span>E: <span>CKR</span&g

23、t;單選題胸腺依賴性抗原A: <span>是胸腺中產(chǎn)生的抗原</span>B: <span>是只能引起細(xì)胞免疫應(yīng)答的抗原</span>C: <span>是只能引起體液免疫應(yīng)答的抗原</span>D: <span>是具有T細(xì)胞表位的抗原</span>E: <span>是具有T細(xì)胞表位又有B細(xì)胞表位的抗原</span>單選題適應(yīng)性免疫應(yīng)答啟動階段發(fā)生于感染A: <span>04小時內(nèi)</span>B: <span>448小時內(nèi)</span

24、>C: <span>496小時內(nèi)</span>D: <span>96小時后</span>E: <span>120小時后</span>單選題存在于不同種屬之間的共同抗原稱為A: <span>異種抗原</span>B: <span>同種異型抗原</span>C: <span>超抗原</span>D: <span>異嗜性抗原</span>E: <span>胸腺非依賴性抗原</span>單選題免疫監(jiān)視功能低

25、下的機(jī)體易發(fā)生A: <span>惡性腫瘤</span>B: <span>超敏反應(yīng)</span>C: <span>移植排斥反應(yīng)</span>D: <span>免疫耐受 </span>E: <span>自身免疫病</span>單選題能夠介導(dǎo)吞噬細(xì)胞產(chǎn)生調(diào)理作用的抗體是A: <span>IgG類抗體</span>B: <span>IgM類抗體</span>C: <span>IgA類抗體</span>D: <

26、;span>IgE類抗體</span>E: <span>IgD類抗體</span>單選題ABO血型不符輸血后引起的溶血屬于A: <span>I型超敏反應(yīng) </span>B: <span>型超敏反應(yīng) </span>C: <span>型超敏反應(yīng)</span>D: <span>型超敏反應(yīng)</span>E: <span>不屬于超敏反應(yīng)</span>單選題B1細(xì)胞主要分布于A: <span>血液中</span>B: &l

27、t;span>淋巴液中</span>C: <span>淋巴結(jié)深皮質(zhì)區(qū)</span>D: <span>胸/腹膜腔和腸道固有層淋巴組織中</span>E: <span>外周免疫器官淋巴濾泡內(nèi)</span>單選題組成性表達(dá)HLA-II類分子的細(xì)胞是A: <span>T淋巴細(xì)胞</span>B: <span>血管內(nèi)皮細(xì)胞</span>C: <span>樹突狀細(xì)胞</span>D: <span>神經(jīng)細(xì)胞</span>E:

28、 <span>血管內(nèi)皮細(xì)胞</span>單選題可分泌穿孔素、顆粒酶的細(xì)胞A: <span> Tc淋巴細(xì)胞和B淋巴細(xì)胞 </span>B: <span> Tc淋巴細(xì)胞和NK細(xì)胞 </span>C: <span> B淋巴細(xì)胞和 NK細(xì)胞 </span>D: <span> Tc細(xì)胞和巨噬細(xì)胞 </span>E: <span> B淋巴細(xì)胞和巨噬細(xì)胞 </span>單選題血清中半衰期最長的抗體是A: <span>IgE類抗體</span>

29、B: <span>IgM類抗體</span>C: <span>IgA類抗體</span>D: <span>IgG類抗體</span>E: <span>IgD類抗體</span>單選題T細(xì)胞表面的特征性標(biāo)志是A: <span>CD2</span>B: <span>CD4</span>C: <span>CD8</span>D: <span>TCR</span>E: <span>BCR</sp

30、an>單選題巨噬細(xì)胞表面可直接識別某些病原體或其產(chǎn)物的受體是A: <span>CR-CD3復(fù)合體</span>B: <span>Toll樣受體(TLR)</span>C: <span>BCR-CD79復(fù)合體</span>D: <span>NKG2D</span>E: <span>IgGFc受體</span>單選題T細(xì)胞主要分布于A: <span>淋巴液</span>B: <span>淋巴結(jié)深皮質(zhì)區(qū)</span>C: <

31、;span>粘膜和皮下組織</span>D: <span>外周血</span>E: <span>脾中央動脈周圍淋巴鞘內(nèi)</span>單選題主要由單核巨噬細(xì)胞產(chǎn)生的細(xì)胞因子是A: <span>IL-1</span>B: <span>IL-2</span>C: <span>IL-4 </span>D: <span>IL-5</span>E: <span>G-CSF</span>單選題介導(dǎo)特異性細(xì)胞免疫功能的淋巴細(xì)胞

32、是A: <span>B1細(xì)胞</span>B: <span>NK細(xì)胞t</span>C: <span>?T細(xì)胞</span>D: <span>T細(xì)胞</span>E: <span>NKT細(xì)胞</span>單選題細(xì)胞因子不包括A: <span>淋巴毒素</span>B: <span>過敏毒素</span>C: <span>白細(xì)胞介素</span>D: <span>干擾素</span>

33、E: <span>集落刺激因子</span>單選題啟動補(bǔ)體經(jīng)典途徑活化的主要物質(zhì)是A: <span>抗原-抗體復(fù)合物</span>B: <span>細(xì)菌脂多糖</span>C: <span>酵母多糖</span>D: <span>病原體表面的巖藻糖殘基</span>E: <span>病原體表面的甘露糖殘基</span>單選題T細(xì)胞主要分布于淋巴結(jié)A: <span>深皮質(zhì)區(qū)</span>B: <span>淺皮質(zhì)區(qū)<

34、;/span>C: <span>淋巴濾泡</span>D: <span>髓質(zhì)區(qū)</span>E: <span>髓索</span>單選題表達(dá)于APC表面可誘導(dǎo)CTL細(xì)胞產(chǎn)生活化第一信號的物質(zhì)是A: <span> B7-1/2分子</span>B: <span> 抗原肽-MHC-類分子復(fù)合物</span>C: <span> ICAM-1分子</span>D: <span> 抗原肽-MHC-類分子復(fù)合物</span>E: <

35、;span> 脂類抗原-CD1分子復(fù)合物</span>單選題下列哪種物質(zhì)沒有免疫原性A: <span>異嗜性抗原</span>B: <span>抗體 </span>C: <span>補(bǔ)體 </span>D: <span>半抗原 </span>E: <span>細(xì)菌多糖 </span>單選題現(xiàn)代免疫概念的定義是A: <span>機(jī)體抗感染的免疫防御能力</span>B: <span>機(jī)體識別清除自身損傷、衰老細(xì)胞的一種能力</span>C: <span>機(jī)體排除抗原性異物的能力,對機(jī)體都是有利的反應(yīng)</span>D: <span>機(jī)體消除和殺滅自身突變的細(xì)胞能力</span>E: <span>機(jī)體非己抗原異物產(chǎn)生排除和對自身成分產(chǎn)生耐受的的能力&

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論